Antitumor and antimetastatic activity of synthetic hydroxystilbenes through inhibition of lymphangiogenesis and M2 macrophage differentiation of tumor-associated macrophages

Anticancer Research

Volumn 36, Issue 1, 2016, Pages 137-148

  Kimura, Yoshiyuki ^a   Sumiyoshi, Maho ^a   Baba, Kimiye ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Anti lymphangiogenesis; Antimetastasis; Antitumor; Dihydroxystilbenes; M2 macrophages

Indexed keywords

2 HYDROXY 3,4',5 TRIMETHOXYSTILBENE; 2 HYDROXYSTILBENE; 2,3 DIHYDROXYSTILBENE; 3 HYDROXY 4',5 DIMETHOXYSTILBENE; 3 HYDROXYSTILBENE; 3,4 DIHYDROXYSTILBENE; 4 HYDROXY 3 METHOXYSTILBENE; 4 HYDROXYSTILBENE; 4,4 DIHYDROXYSTILBENE; ANTIMETASTATIC AGENT; ANTINEOPLASTIC AGENT; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; STILBENE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN C; CCL2 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; LYMPHANGIOGENESIS; MACROPHAGE ACTIVATION; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ANIMAL; BONE NEOPLASMS; C3H MOUSE; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; LUNG NEOPLASMS; LYMPH VESSEL; MACROPHAGE; METABOLISM; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION; SECONDARY; SIGNAL TRANSDUCTION; SYNTHESIS; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-10; LUNG NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE, INBRED C3H; OSTEOSARCOMA; PHENOTYPE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STILBENES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR C; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84958055104     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda K, Saijo, Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M and Ono M: Infiltration of COX-2-expressing macrophage is a prerequisite for IL-1β-induced neovascularization and tumor growth. J Clin Invest 115: 2979-2991, 2005.
2. Allavena P and Mantovani A: Immunology in the clinic review series; focus on cancer: tumor-associated macrophage: undisputed stars of the inflammatory tumor microenvironment. Clin Exp Immunol 167: 195-205, 2012.
3. Schimieder A, Michel J, Schonjaar K, Goerdt S and Schledzewski K: Differentiation and gene expression profile of tumor-associated macrophages. Semin. Cancer Biol 22: 289-297, 2012.
4. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments, Cancer Res 66: 605-612, 2006.
5. Joyce JA and Pollard JW: Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9: 239-252, 2009.
6. Sica A, Schioppa T, Mantovani A and Allavena P: Tumorassociated macrophages are a distinct M2 polarised population promoting tumor progression: potential targets of anticancer therapy. Eur J Cancer 42: 717-727, 2006.
7. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani A: Macrophage polarization in tumor progression. Semin Cancer Biol 18: 349-355, 2008.
8. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003.
9. Mosser DM: The many faces of macrophage activation. J Leukoc Biol 73: 209-212, 2003.
10. Mantovani A, Sica A, Sozzani S, Allavens P, Vecchi A and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686, 2004.
11. Hata K, Kozawa M and Baba K: New stilbene glycoside from Chinese crude drug Heshouwu. Roots of Polygonum multiflorium. Yakugaku Zasshi 95: 211-213, 1975.
12. Hata K, Baba K and Kozawa M: Chemical studies on the heartwood of Cassia garrettiana Craib. II. Nonanthraquinonic constituents. Chem Pharm Bull 27: 984-989, 1979.
13. Kimura Y, Kozawa M, Baba K and Hata K: New constituents of roots of Polygonum cuspidatum. Planta Med 48: 164-169, 1983.
14. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M and Arichi S: Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull 30: 1766-1770, 1982.
15. Kimura Y, Okuda H and Arichi S: Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 834: 275-278, 1985.
16. Kimura Y: Pharmacological studies on resveratrol. Methods Find Exp Clin Pharmacol 25: 297-310, 2003.
17. Baur JA: Biochemical effects of SIRT1 activators. Biochim Biophys Acta 1804: 1626-1634, 2010.
18. Baur JA: Resveratrol, sirtuins, and the promise of DR mimetic. Mech Ageing Dev 131: 261-269, 2010.
19. Savio M, Coppa T, Bianchi L, Vannini V, Maga G, Forti L, Cazzalini O, Lazze MC, Perucca P, Prosperi E and Stivala LA: The resveratrol analogue 4,4′-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol. Int J Biochem Cell Biol 41: 2493-2502, 2009.
20. Maccario C, Savio M, Ferraro D, Bianchi L, Pizzala R, Pretali L, Forti L and Stivala LM: The resveratrol analog 4,4′-dihydroxytrans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells. Carcinogenesis 33: 2172-2180, 2012.
21. +- ATPase. Biochem Pharmacol 67: 663-665, 1992.
22. Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao TH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, Yang PC, Kuo ML and Jee SH: Tumor-associated macrophage-induced invasion and angiogenesis of human basal carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 129: 1016-1025, 2009.
23. Kimura Y, Sumiyoshi M and Baba K: Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci 99: 2083-2096, 2008.
24. Kimura Y and Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinomabearing mice. J Nutr 131: 1844-1849, 2001.
25. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Nat Cancer Inst 82: 4-6, 1990.
26. Mandorita SJ, Jussila L, Jetsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G and Pepper MS: Vascular endothelial growth factor-C-meditated lymphangiogenesis promotes tumor metastasis. EMBO J 20: 672-682, 2001.
27. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Roccardi L, Alitalo K, Claffey K and Detmar M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nature Med 7: 192-198, 2001.
28. Ueda M, Hung Y-C, Terai Y, Kanada K, Kanemura M, Futakuchi H, Yamaguchi H, Akise D, Yasuda M and Ueki M: Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin Cancer Res 11: 3225-3232, 2005.
29. Okudera K, Kamata Y, Takahashi S, Hasegawa Y, Tsushima T, Ogura Y, Nakanishi K, Sato H and Okumura K: Small adenocarcinoma of the lung: prognostic significance of central fibrosis chiefly because of its association with angiogenesis and lymphangiogenesis. Pathol Int 56: 494-502, 2006.
30. Kimura Y and Sumiyoshi M: Antitumor and antimetastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Phytomedicine 20: 328-336, 2013.
31. Sumiyoshi M, Taniguchi M, Baba K and Kimura Y: Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots through the inhibited activation and differentiation of M2 macrophages. Phytomedicine 22: 759-767, 2015.
32. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I and Akira S: Enhanced The activity and development of chronic enterocolitis in mice devoid of STAT3 in macrophages and neutrophils. Immunity 10: 39-49, 1999.
33. Matsukawa A, Takeda K, Kudo S, Maeda T, Kagayama M and Akira S: Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J Immunol 171: 6198-6205, 2003.
34. Yu H, Kortylewski M and Pardoll D: Crosstalk between cancer and immune cell: Role of STAT3 in the tumor microenvironment. Nat Rev Immunol 7: 41-51, 2007.
35. Sica A and Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117: 1155-1166, 2007.
36. Shi VY, Bao L and Chan LS: Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4-transgenic mouse model. Microcircul 19: 567-579, 2012.
37. Poosti F, Yazdani S, Dolman MEM, Kok R, Chen C, Ding G, Lacombe M, Prakash J, van den Born J, Hillebrands J-L, van Goor H and de Borst MH: Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection. Eur J Pharmacol 694: 111-119, 2012.
38. Watari K, Shibata T, Kawahara A, Sata K, Mabeshima H, Hinoda A, Abe H, Azuma K, Murakami Y, Izumi H, Takahashi T, Kage M, Kuwano M and Ono M: Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages. PloS One 9: e99568, 2014.
39. Lee KM, Danuser R, Stein JV, Graham D, Nibbs RJB and Graham GJ: The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density. EMBO J 33: 2564-2580, 2014.
40. Maeng Y-S, Aguilar B, Choi S-I and Kim EK: Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis. Oncogene online publication 16 March 2015; doi. 10.1038/onc. 2015.73, 2015.
41. Lee AS, Lee JE, Jung YJ, Kim DH, Kang KP, Lee S, Park SK, Lee SY, Kang MJ, Moon WS, Kim HJ, Jeong YB, Sung MJ and Kim W: Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int 83: 50-62, 2012.